Thomas D. Szucs

University of Basel — Switzerland

Economics, Econometrics and Finance · Social Sciences

47h-index8.3kcitations401works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(99), Pharmaceutical Economics and Policy(49), Influenza Virus Research Studies(38), Vaccine Coverage and Hesitancy(36), Lipoproteins and Cardiovascular Health(26)

Publications401 total

[Tattoo ink between beauty and risk: regulation in Switzerland, the EU and the USA].
PubMed·2025
Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study data
Swiss Medical Weekly·2025Open Access
Music Therapy and Skill Development in Children with Autism Spectrum Disorder: A Systematic Review
Journal of Psychiatry and Psychiatric Disorders·2025Open Access
Monitorage des performances et de la santé dans le sport d’élite
Jusletter·2025
Effectiveness of Music Interventions on Chronic Pain: A Systematic Review
Journal of Psychiatry and Psychiatric Disorders·2025Open Access
Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022
BMC Medicine·2024· 1 citedOpen Access
[Medicine and Law: an Introduction - Part 1].
PubMed·2024
[The knowledge of medical law among medical students and medical service providers in Switzerland].
PubMed·2024
[Medicine and Law: an Introduction - Part 2].
PubMed·2024
Bedside manufacturing as the next step in personalized medicine: medical progress and legal challenges
Journal of Law and the Biosciences·2024· 3 citedOpen Access
Heart rate variability and stroke or systemic embolism in patients with atrial fibrillation
Heart Rhythm·2024· 11 citedOpen Access
Postgraduate education and training in drug development sciences: 30 years of the european center of pharmaceutical medicine
Frontiers in Pharmacology·2024· 6 citedOpen Access
Swiss Policy Brief on Implementing Medication Adherence Interventions
Lirias (KU Leuven)·2024
Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort
Open Heart·2024· 2 citedOpen Access
Longitudinal Changes in Health‐Related Quality of Life in Patients With Atrial Fibrillation
Journal of the American Heart Association·2023· 2 citedOpen Access
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls
BMJ Open·2023· 3 citedOpen Access
Consensus recommendations on how to assess the quality of surgical interventions
Nature Medicine·2023· 85 citedOpen Access
Data from <i>KRAS</i> and <i>BRAF</i> Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective
2023Open Access
Appendix (1-4) from <i>KRAS</i> and <i>BRAF</i> Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective
2023Open Access
Appendix (1-4) from <i>KRAS</i> and <i>BRAF</i> Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Matthias Schwenkglenks(18), Patricia R. Blank(8), Ruth Pettengell(5), Robert Paridaens(5), W. Schramm(4), Robert Leonard(4), André Bosly(4), Manuel Constenla(4), Christian Jackisch(4), Stefan Osswald(3), Barbara L. Kroner(3), S.M. Ess(2), David Conen(2), Nicolas Rodondi(2), Jürg H. Beer(2), Giorgio Moschovitis(2), Richard Kobza(2), Stefanie Aeschbacher(2), Steffen Blum(2), Christian Sticherling(2)